Send to

Choose Destination
J Urol. 1979 Aug;122(2):163-4.

The incidence of bladder cancer after cyclophosphamide therapy.


The records of 19,082 patients with non-uroepithelial cancers were reviewed to determine the incidence of de novo bladder cancer in patients treated with cyclophosphamide versus patients not treated with this drug. A 9-fold increased incidence of bladder cancer was found in the cyclophosphamide-treated group.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center